59762-0152-1 : NDC 2026 Code

59762-0152-1 : Trandolapril And Verapamil Hydrochloride ( Trandolapril And Verapamil Hydrochloride )

Additionally :

You can get information about “59762-0152-1” NDC code in 59762-0152-1 in HTML format

HTML | 59762-0152-1 in TXT (Plain Text) format

TXT | 59762-0152-1 in PDF (Portable Document Format)

PDF | 59762-0152-1 in XML format

XML formats.

NDC Code : 59762-0152-1 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "59762-0152-1",
    "PackageDescription": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59762-0152-1)",
    "NDC11Code": "59762-0152-01",
    "ProductNDC": "59762-0152",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Trandolapril And Verapamil Hydrochloride",
    "ProprietaryNameSuffix": "Er",
    "NonProprietaryName": "Trandolapril And Verapamil Hydrochloride",
    "DosageFormName": "TABLET, FILM COATED, EXTENDED RELEASE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20150225",
    "EndMarketingDate": "20180228",
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA020591",
    "LabelerName": "Greenstone LLC",
    "SubstanceName": "TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE",
    "StrengthNumber": "1; 240",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2018-03-01",
    "PackageNdcExcludeFlag": null,
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20181231",
    "StartMarketingDatePackage": null,
    "EndMarketingDatePackage": null,
    "SamplePackage": null
  }
}